Market Research Future adds new report of “Global Pharmacogenomics Market Research Report - Forecast to 2027” it contains Company information, geographical data and Table of Content

Competitive Analysis:

The key players that are involved in global pharmacogenomics market Myriad 

•    Genetics Inc. (U.s)
•    Transgenomic Inc. (U.s)
•    23andMe (U.S)
•    Pathway Genomics (CA)
•    Genetech (CA)
•    GeneDX (U.S)
•    Teva ... Read more

According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.

The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025). ... Read more

A) Market Overview:
Pharmacogenomics is the study of how a person's genetic makeup affects their response to drugs. It involves analyzing a patient's DNA to determine their likelihood of responding to a particular medication. This information can then be used to personalize the treatment plan and optimize drug effectiveness. Pharmacogenomics has gained significant popularity in recent years due to its potential to improve patient outcomes and reduce adverse ... Read more

The pharmacogenomics market is estimated to be valued at US$ 33079.39 Mn in 2023 and is expected to exhibit a CAGR of 11.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Pharmacogenomics is a science that studies how genes affect individual's response to drugs. It analyses how inherited genetic differences influence drug response. ... Read more